rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: american health packaging
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler american health packaging
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 1.5 mg/1

Manufacturer
American Health Packaging

Identifiers & Regulatory

Product NDC 60687-777
Product ID 60687-777_4352c1c1-8fb2-d457-e063-6294a90ab64b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077130
Listing Expiration 2026-12-31
Marketing Start 2024-01-01

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 60687777
Hyphenated Format 60687-777

Supplemental Identifiers

RxCUI
314214
UNII
9IY2357JPE

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA077130 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.5 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 CARTON (60687-777-01) / 1 CAPSULE in 1 BLISTER PACK (60687-777-11)
source: ndc

Packages (1)

Ingredients (1)

rivastigmine tartrate (1.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4352c1c1-8fb2-d457-e063-6294a90ab64b", "openfda": {"unii": ["9IY2357JPE"], "rxcui": ["314214"], "spl_set_id": ["52781229-ee82-43f9-a113-4419a611978d"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (60687-777-01)  / 1 CAPSULE in 1 BLISTER PACK (60687-777-11)", "package_ndc": "60687-777-01", "marketing_start_date": "20240101"}], "brand_name": "Rivastigmine Tartrate", "product_id": "60687-777_4352c1c1-8fb2-d457-e063-6294a90ab64b", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "60687-777", "generic_name": "Rivastigmine Tartrate", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "1.5 mg/1"}], "application_number": "ANDA077130", "marketing_category": "ANDA", "marketing_start_date": "20240101", "listing_expiration_date": "20261231"}